We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
RANDOX LABORATORIES

Diatron MI Plc

Develops, manufactures and markets hematology analyzers, clinical chemistry analyzers, and associated reagents for hu... read more Featured Products: More products

Download Mobile App




Advanced Hematology Analyzer Brings Simplicity and Efficiency to Decentralized Healthcare Facilities

By LabMedica International staff writers
Posted on 02 Jan 2023

A new hematology analyzer is all set to bring unrivaled simplicity and efficiency to the decentralized market segment. More...

Diatron (Budapest, Hungary) has announced the launch of Aquarius 3, its latest IVD hematology analyzer for Complete Blood Count testing. Aquarius 3 will be the first in a new family of hematology analyzers from Diatron. Evolving from the Abacus 380, Diatron’s flagship analyzer, the Aquarius 3 incorporates similar robust and trusted counting technology but is equipped with new features to improve operability and connectivity, allowing it to adapt to diverse environments for the benefit of both customers and users alike.

While still retaining the important features of the Abacus 380, the Aquarius 3 has many other product enhancements, with the most obvious change being the addition of an 8” high resolution, color touch screen, making it clear and simple to operate. Other features include 1D/2D barcode scanner for sample ID, QC and reagent management (closed system), 25 μl sampling volume, including micro‐tube capability, increased database capacity with 10,000 + USB mass storage, and a wider choice of external printers. In line with its predecessors, the new Aquarius 3 is easy to use, flexible and suitable for a variety uses such as in doctor’s offices, low to mid‐size laboratories and other decentralized healthcare facilities.

Related Links:
Diatron 


Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Online QC Software
Acusera 24•7
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Ultrasensitive ctDNA Assay Detects MRD in Breast, Colorectal, Renal Cancers

Minimal residual disease testing is increasingly used to guide adjuvant therapy and surveillance in solid tumors, but detecting very low levels of circulating tumor DNA remains challenging in routine practice.... Read more

Microbiology

view channel
Image: Multidrug-resistant Klebsiella pneumoniae is a growing community health concern, causing recurrent UTIs in older adults and complicating first-line antibiotic treatment (Image Credit: Adobe Stock)

Study Reveals Widespread Community Spread of Drug-Resistant Klebsiella

Multidrug-resistant Klebsiella pneumoniae is an escalating community health concern, driving recurrent urinary tract infections in older adults and complicating first-line antibiotic therapy.... Read more

Industry

view channel
Image: The proposed immunoassay uses ALZpath’s pTau217 antibody to detect Alzheimer’s disease biology in blood, supporting the growing role of blood-based biomarkers in clinical care (Photo courtesy of Shutterstock)

Agreement Supports pTau217-Based Alzheimer’s Blood Test Development

As disease-modifying therapies for Alzheimer’s disease expand, accessible diagnostics are increasingly needed to identify patients earlier. Current confirmatory methods, including PET imaging and cerebrospinal... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.